Clinical Profile of Cardiac Autonomic Neuropathy in Diagnosed Patients of Type 2 Diabetes Mellitus

Jump To References Section

Authors

  • Neelima Chafekar
     Professor and HOD, Department of Medicine, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Adgaon, Nashik – 422003, Maharashtra ,IN
  • Jitendra Kodilkar
     Assistant Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Adgaon, Nashik – 422003, Maharashtra ,IN
  • Parth Deogaonkar
     PG Student, Department of Medicine, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Adgaon, Nashik – 422003, Maharashtra ,IN
  • Maansi Gujarathi
     PG Student, Department of Medicine, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Adgaon, Nashik – 422003, Maharashtra ,IN

DOI:

https://doi.org/10.18311/mvpjms/2018/v5i2/721

Keywords:

Cardiac Autonomic Neuropathy, Diabetes Mellitus, Diabetic Neuropathy, Diabetic Nephropathy, Diabetic Retinopathy
Disorders of the Heart

Abstract

Background: Diabetes mellitus (DM) is a clinical syndrome characterized by hyperglycemia caused by relative or absolute deficiency of insulin1. Cardiac autonomic neuropathy is a complication of diabetes. Our study intends to study Cardiac Autonomic Neuropathy in diabetics attending our hospital. Aims and Objectives: To study the clinical profile of Cardiac Autonomic Neuropathy in type 2 DM. Materials and Method: The study was carried out in a tertiary care hospital. The data was collected from August 2013 to December 2015 in 54 patients. The history, examination and bedside tests were done and conclusions drawn. Tests performed included heart rate response to deep breathing, standing, valsalva maneuver; BP response to sustained handgrip and standing. Results: Of 54 patients studied, 25 (46.29%) had CAN. Of the 25 patients affected with CAN 3 were between age 41-50, 10 between 51-60, 10 in 61-70 and 2 in 71-80. Out of 25 patients having CAN in the study 14 (56%) are male and 11 (44%) are female. Mean age of patients having CAN was 10.36 as compared to 6.55 in those not having CAN. Our study gave the following. Conclusions: Cardiac Autonomic Neuropathy is one of the most common but under diagnosed complications of diabetes mellitus. Cardiac Autonomic Neuropathy is associated with both type 1 and type 2 Diabetes Mellitus. It correlates with the duration and age. Resting tachycardia is a signs of autonomic dysfunction. Heart rate response to deep breathing and B.P. response to sustained hand grip are the most sensitive and specific tests for diagnosis of autonomic dysfunction. Cardiac Autonomic Neuropathy is significantly associated with other microvascular complications of DM like Diabetic retinopathy and nephropathy.

Downloads

Published

2019-04-17

Issue

Volume 5, Issue 2, July - December 2018

Section

Original Research Article

 

References

Frier B, Fisher M. Diabetes mellitus, Davidson's principles and practice of medicine. Boon, Colledge, Walker, Hunter, editors. 21st ed. Churchill Livingstone; 2010. p. 795–840.

Vinik et al. Diabetic autonomic neuropathy. American Diabetes Association, Diabetes Care. 2003 May; 26(5): 1553–79. https://doi.org/10.2337/diacare.26.5.1553 PMid :12716821

Ewing DJ, Clarke BF. Diabetic autonomic neuropathy: present insights and future prospects. Diabetes Care. 1986 Nov-Dec; 9(6): 648–65. https://doi.org/10.2337/diacare.9.6.648 PMid:3100258

Freeman R, The nervous system and diabetes, Joslin's Diabetes mellitus. Kahn C, Weir G, King G, Moses A, Smith R, editor. 14th ed. Lippincott Williams and Wilkins; 2006. p. 952–78.

Karavanaki K, Baum JD. Prevalence of microvascular and neurologic abnormalities in a population of diabetic children. J Pediatr Endocrinol. 1999; 12:411–22. https://doi.org/10.1515/JPEM.1999.12.3.411

Basu AK, et al. A study on the prevalence of cardiac neuropathy in type-2 diabetes in Eastern India. JIACM. 2011; 13(1):22–6.

Sinha PK, et al. Carotid intima-media thickness in type 2 diabetes mellitus patients with cardiac autonomic neuropathy. Journal of the Association of Physicians of India. 2012 Sep; 60:44–7.

Alexandra et al. Subclinical diagnosis of cardiac autonomic neuropathy in type 2 diabetes: Prevalence, severity, correlations with time, metabolic and vascular factors. Romanian Journal of neurology. 2010; 11(1):28–32.

Ahmed et al. Diabetic autonomic neuropathy. Saudi Med J. 2000 Nov; 21(11):1034–7. PMid:11360064

Kempler, et al. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabet Med. 2002 Nov; 19(11): 900–9.

https://doi.org/10.1046/j.1464-5491.2002.00821.x PMid:12421426

Spallone V, et al. Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes. Diabetes Res Clin Pract. 1997 Jan; 34(3):169–79.

https://doi.org/10.1016/S0168-8227(96)01354-X

Magri CJ, et al. The Diabetic Eye: A window to the heart and vascular system. J Diabetes Metab. 2012; S3. https://doi.org/10.4172/2155-6156.S3-008

Valensi, et al. Cardiac autonomic neuropathy in diabetic patients: Influence of diabetes duration, obesity, and microangiopathic complications- The French multicenter study. Metabolism. 2003 Jul; 52(7):815–20. https://doi.org/10.1016/S0026-0495(03)00095-7

Kubo K, et al. Studies of the relationship between diabetic retinopathy and progression of diabetic neuropathy. Medical Journal of Hiroshima perfectual hospital. 1999; 31(1):23–6.